This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Doxycycline

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20220825

Version

6

Spl Product Data Elements

doxycycline doxycycline DOXYCYCLINE DOXYCYCLINE ANHYDROUS SILICON DIOXIDE GELATIN MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO TITANIUM DIOXIDE FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC AMMONIA OPAQUE YELLOW OPAQUE WHITE CAPSULE 782 doxycycline doxycycline DOXYCYCLINE DOXYCYCLINE ANHYDROUS SILICON DIOXIDE GELATIN MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO TITANIUM DIOXIDE D&C YELLOW NO. 10 FD&C BLUE NO. 1 FD&C RED NO. 3 FD&C YELLOW NO. 6 FERROSOFERRIC OXIDE POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC AMMONIA OPAQUE ORANGE OPAQUE WHITE CAPSULE 706 doxycycline doxycycline DOXYCYCLINE DOXYCYCLINE ANHYDROUS SILICON DIOXIDE GELATIN MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO TITANIUM DIOXIDE FERRIC OXIDE YELLOW D&C YELLOW NO. 10 FD&C BLUE NO. 1 FD&C RED NO. 3 FD&C YELLOW NO. 6 FERRIC OXIDE RED FERROSOFERRIC OXIDE POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC AMMONIA OPAQUE YELLOW OPAQUE ORANGE CAPSULE 707

Application Number

ANDA205115

Brand Name

Doxycycline

Generic Name

doxycycline

Product Ndc

65841-823

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-821-01 in bottle of 100 Capsules Doxycycline Capsules USP, 50 mg Rx Only 100 Capsules NDC 65841-822-01 in bottle of 100 Capsules Doxycycline Capsules USP, 75 mg Rx Only 100 Capsules NDC 65841-823-01 in bottle of 100 Capsules Doxycycline Capsules USP, 100 mg Rx Only 100 Capsules Doxycycline Capsules 50 mg Doxycycline Capsules 75 mg Doxycycline Capsules 100 mg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.